These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9256917)

  • 1. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
    Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
    Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
    Basarab T; Orchard G; Russell-Jones R
    Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Basal Cell Carcinoma and Trichoepithelioma: An Immunohistochemical Study.
    Carrasquillo OY; Cruzval-O'Reilly E; Sánchez JE; Valentín-Nogueras SM
    Am J Dermatopathol; 2021 Mar; 43(3):191-197. PubMed ID: 32809979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
    Poniecka AW; Alexis JB
    Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichoepithelioma: a 19-year clinicopathologic re-evaluation.
    Bettencourt MS; Prieto VG; Shea CR
    J Cutan Pathol; 1999 Sep; 26(8):398-404. PubMed ID: 10551412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens.
    Mostafa NA; Assaf M; Elhakim S; Abdel-Halim MRE; El-Nabarawy E; Gharib K
    J Cutan Pathol; 2018 Nov; 45(11):807-816. PubMed ID: 29917261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
    Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
    J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.
    Ionescu DN; Arida M; Jukic DM
    Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostaining for CD34 to determine trichoepithelioma.
    Bryant D; Penneys NS
    Arch Dermatol; 1995 May; 131(5):616-7. PubMed ID: 7537953
    [No Abstract]   [Full Text] [Related]  

  • 18. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
    Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
    Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
    Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index.
    Stamp GW; Nasim M; Cardillo M; Sudhindra SG; Lalani EN; Pignatelli M
    Br J Dermatol; 1993 Jul; 129(1):57-64. PubMed ID: 8103666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.